Resilient Biotics
Raleigh
About Resilient Biotics
Resilient Biotics utilizes big data analytics to design microbiome-based therapeutics and advanced screening methods for prevention and treatment of deadly infectious diseases, with an initial focus on combating respiratory diseases in livestock animals. Resilient’s goal is to provide more effective treatment strategies while reducing the livestock industry’s current dependency on antibiotics.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $7.2M
- Funding stage: Early Stage Venture
- Last round: Series A (Jan 2021)
- Website: resilientbiotics.com
- Phone: 717-350-3133
Industries & Categories
Analytics, Biotechnology, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/resilient-biotics-147887 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.